NPI registry status
Active
2026 NPPES data Rheumatology Physician NPI 1194287185 M.D.
Verify on CMS → Michael Macklin, M.D.
Rheumatology Physician in Chicago, Illinois.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,181 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
796
Medicare Part D claims · 191 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$4.3K
33 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Michael Macklin, M.D. filed 796 Medicare Part D claims in 2023 as a Rheumatology Physician in Chicago, Illinois, prescribing 85% generic.
- 796
- Part D claims, 2023
- 85%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Michael Macklin, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
796 Top 29% higher than 71% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Michael Macklin, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Macklin, M.D.?
Quality data not reportedPrimary specialty
Rheumatology Physician
Medicare Part D claims
796 61% vs specialty avg
Specialty distribution in Illinois
How Rheumatology Physician compares to other specialties among Illinois providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Rheumatology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michael Macklin, M.D. appears in the CMS NPPES registry as a Rheumatology Physician provider holding M.D. credentials at 5841 S MARYLAND AVE, Chicago, IL, 60637, with a listed phone of (773) 702-6119. NPI 1194287185 was issued on 04/01/2019.
Medicare Part D records for calendar year 2023 show 796 prescription claims written by this provider, covering 191 Medicare beneficiaries and totaling roughly $494K in drug spend, split 15% brand-name and 85% generic by claim count.
Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1194287185 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/01/2019 |
Hospital and facility affiliations
Facilities where Michael Macklin, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
The University OF Chicago Medical Center
★★★★☆ 4/5
Chicago, IL
Acute Care Hospitals
CMS CCN: 140088
University OF Chicago
Crown Point, IN
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Macklin, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$4.3K
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Illinois IDFPR 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to Michael Macklin, M.D.. To verify Michael Macklin, M.D.'s current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Michael Macklin, M.D. - brand share 15.0%
Rheumatology Physician average
15% brand-name claims vs 85% generic, on 796 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
796
Total Claims
$494K
Total Drug Cost
191
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,389
- Total Day Supply
- 40,166
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $438K
- Generic Drug Cost
- $56K
Patient Demographics
- Average Patient Age
- 66.9 years
- Avg HCC Risk Score
- 2.21
- Gender Split
- 82% female / 18% male
- Age Distribution
- <65: 62, 65-74: 78, 75-84: 40, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Macklin, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Methotrexate
Methotrexate
138 claims
- Prednisone
Prednisone
103 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
63 claims
- Duloxetine Hcl 38
Duloxetine Hcl
38 claims
- Leflunomide 29
Leflunomide
29 claims
- Diclofenac Sodium 27
Diclofenac Sodium
27 claims
- Humira Pen 27
Humira Pen
27 claims
- Gabapentin 26
Gabapentin
26 claims
| Drug | Claims |
|---|---|
| Methotrexate Methotrexate Sodium | 138 |
| Prednisone | 103 |
| Hydroxychloroquine Sulfate | 63 |
| Duloxetine Hcl | 38 |
| Leflunomide | 29 |
| Diclofenac Sodium | 27 |
| Humira Pen Adalimumab | 27 |
| Gabapentin | 26 |
| Sulfasalazine | 23 |
| Mycophenolate Mofetil | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Michael Macklin, M.D. fits within the Rheumatology Physician landscape nationally.
6,181
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,054
Avg Claims per Provider
Michael Macklin, M.D.'s 796 claims are below the specialty average of 2,054.
Nearby Rheumatology Physician Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Macklin.
Dr. Elaine Adams
MD
Maywood, IL
Dr. Emem Adolf-Ubokudom
M.D.
Chicago, IL
Dr. Shri Agrawal
M.D.
Chicago, IL
Dr. Umber Ahmad
DO
McHenry, IL
Saba Ahmed
Chicago, IL
Compare Rheumatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Illinois medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Rheumatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Illinois
Frequently Asked Questions
What is Michael Macklin, M.D.'s specialty? ▼
Michael Macklin, M.D. specializes in Rheumatology Physician and practices in Chicago, Illinois. Credentials: M.D..
How much does Michael Macklin, M.D. prescribe under Medicare Part D? ▼
In 2023, Michael Macklin, M.D. wrote 796 Medicare Part D claims totaling $494K in drug costs for 191 beneficiaries.
Where is Michael Macklin, M.D. located? ▼
Michael Macklin, M.D. is located at 5841 S MARYLAND AVE, Chicago, IL, 60637. Phone: (773) 702-6119.
What is Michael Macklin, M.D.'s NPI number? ▼
Michael Macklin, M.D.'s National Provider Identifier (NPI) is 1194287185, issued on 04/01/2019.
Does Michael Macklin, M.D. prescribe more brand-name or generic drugs? ▼
Michael Macklin, M.D.'s prescribing is 15% brand-name and 85% generic drugs by claim count, with $438K in brand drug costs.
How many Rheumatology Physician providers are there in the US? ▼
There are 6,181 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,054 Medicare Part D claims per year.
What drugs does Michael Macklin, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Michael Macklin, M.D.'s most frequently prescribed drugs include Methotrexate, Prednisone, Hydroxychloroquine Sulfate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Macklin, M.D. accept Medicare? ▼
Michael Macklin, M.D. appears in CMS Medicare data with 796 Part D claims and 191 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Macklin, M.D.'s credentials? ▼
Michael Macklin, M.D.'s NPI is 1194287185 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.